BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33902378)

  • 1. Association between the Genetic Polymorphisms of
    Shao LN; Zhou SH; Wang N; Zhang ST; Liu M
    Immunol Invest; 2022 Jul; 51(5):1182-1197. PubMed ID: 33902378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic polymorphisms of chemokines and their receptors with clearance or persistence of hepatitis C virus infection.
    El-Bendary M; Neamatallah M; Elalfy H; Besheer T; El-Setouhy M; Youssef MM; Zein M; Elhammady D; Hegazy A; Esmat G
    Br J Biomed Sci; 2019 Jan; 76(1):11-16. PubMed ID: 30175654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of chemokines and their receptors genes polymorphisms with risk of myocardial infarction].
    Xu X; Wang LH; Liu HB; Xu CF; Zhang P; Yong F; Shi YP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):601-7. PubMed ID: 24078580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of CCL2, CCL5, CCR2 and CCR5 genes in Sahariya tribe of North Central India: an association study with pulmonary tuberculosis.
    Mishra G; Poojary SS; Raj P; Tiwari PK
    Infect Genet Evol; 2012 Jul; 12(5):1120-7. PubMed ID: 22554651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.
    Li H; Liu TJ; Hong ZH
    Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Polymorphism at
    Batista AM; Alvarado-Arnez LE; Alves SM; Melo G; Pereira IR; Ruivo LAS; da Silva AA; Gibaldi D; da Silva TDESP; de Lorena VMB; de Melo AS; de Araújo Soares AK; Barros MDS; Costa VMA; Cardoso CC; Pacheco AG; Carrazzone C; Oliveira W; Moraes MO; Lannes-Vieira J
    Front Immunol; 2018; 9():615. PubMed ID: 29696014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
    Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
    Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs.
    Huik K; Avi R; Pauskar M; Kallas E; Jõgeda EL; Karki T; Rüütel K; Talu A; Abel-Ollo K; Uusküla A; Carrillo A; Ahuja SK; He W; Lutsar I
    PLoS One; 2016; 11(6):e0156850. PubMed ID: 27304910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine and chemokine receptor gene polymorphism in Tunisian hemodialysis patients with HCV infection.
    Ksiaa Cheikh Rouhou L; Gorgi YL; Skhiri HA; Aouadi H; Ayed SJ; Sfar I; Ayed K; Ben Abdallah T
    Arab J Nephrol Transplant; 2011 Sep; 4(3):117-24. PubMed ID: 22026334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection.
    Hellier S; Frodsham AJ; Hennig BJ; Klenerman P; Knapp S; Ramaley P; Satsangi J; Wright M; Zhang L; Thomas HC; Thursz M; Hill AV
    Hepatology; 2003 Dec; 38(6):1468-76. PubMed ID: 14647058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of IL-17A, IL-17F, IL-23R, VDR, CCL2, CCL5, CCR2, and CCR5 gene polymorphisms and expression in Chinese individuals with syphilis.
    Hu WL; Ren H; Xu BF; Zhang JP; Zhang RL; Wang QQ; Zhang TT
    J Cell Biochem; 2018 Dec; 119(12):10151-10164. PubMed ID: 30171709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
    Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
    Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic associations and epistatic effects of the CCR5 promoter and CCR2-V64I polymorphisms on susceptibility to HIV-1 infection in a Northern Han Chinese population.
    Lu J; Sheng A; Wang Y; Zhang L; Wu J; Song M; He Y; Yu X; Zhao F; Liu Y; Shao S; Lan J; Wu H; Wang W
    Genet Test Mol Biomarkers; 2012 Dec; 16(12):1369-75. PubMed ID: 23057571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan.
    Konishi I; Horiike N; Hiasa Y; Michitaka K; Onji M
    Intervirology; 2004; 47(2):114-20. PubMed ID: 15192276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source.
    Goulding C; McManus R; Murphy A; MacDonald G; Barrett S; Crowe J; Hegarty J; McKiernan S; Kelleher D
    Gut; 2005 Aug; 54(8):1157-61. PubMed ID: 15863470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population.
    Cheong JY; Cho SW; Choi JY; Lee JA; Kim MH; Lee JE; Hahm KB; Kim JH
    J Korean Med Sci; 2007 Jun; 22(3):529-35. PubMed ID: 17596666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia.
    Pang Y; Li H; Gong Y; Jing S; Peng C; Liu W; Zhao Y; Wang H; Kaushik D; Rodriguez R; Wang Z
    Oncol Rep; 2019 Apr; 41(4):2491-2501. PubMed ID: 30816510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of CCL2, CCL5 and CCR2 polymorphisms for adverse prognosis of Japanese encephalitis from an endemic population of India.
    Chowdhury P; Khan SA
    Sci Rep; 2017 Oct; 7(1):13716. PubMed ID: 29057937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
    Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
    Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in CCL2&CCL5 chemokines/chemokine receptors genes and their association with diseases.
    Navratilova Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Nov; 150(2):191-204. PubMed ID: 17426779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.